Express Scripts (ESRX) Earns Equal Weight Rating from Analysts at Barclays

Barclays started coverage on shares of Express Scripts (NASDAQ:ESRX) in a report issued on Thursday, Marketbeat Ratings reports. The firm issued an equal weight rating and a $84.00 target price on the stock.

Several other research analysts have also commented on the stock. Zacks Investment Research upgraded shares of Express Scripts from a hold rating to a buy rating and set a $84.00 price target on the stock in a report on Tuesday, March 6th. Maxim Group raised their price target on shares of Express Scripts from $87.00 to $101.00 in a report on Wednesday, February 28th. Jefferies Group set a $91.00 price target on shares of Express Scripts and gave the company a buy rating in a report on Wednesday, February 28th. Bank of America assumed coverage on shares of Express Scripts in a research note on Tuesday, February 27th. They set an underperform rating and a $77.00 price objective on the stock. Finally, BidaskClub upgraded shares of Express Scripts from a hold rating to a buy rating in a research note on Friday, February 23rd. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Express Scripts has an average rating of Hold and an average target price of $81.97.

Express Scripts (ESRX) opened at $80.75 on Thursday. Express Scripts has a 1-year low of $55.80 and a 1-year high of $85.07. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.67 and a quick ratio of 0.55. The company has a market cap of $45,319.88, a P/E ratio of 11.34, a P/E/G ratio of 0.99 and a beta of 0.94.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $2.16 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.09 by $0.07. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. The firm had revenue of $25.38 billion for the quarter, compared to analyst estimates of $25.07 billion. During the same quarter last year, the firm posted $1.88 earnings per share. Express Scripts’s revenue for the quarter was up 2.1% compared to the same quarter last year. equities analysts expect that Express Scripts will post 9.35 EPS for the current fiscal year.

Express Scripts announced that its board has initiated a share repurchase plan on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

In other news, VP Glen D. Stettin sold 3,449 shares of the firm’s stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total transaction of $279,369.00. Following the completion of the sale, the vice president now owns 33,715 shares of the company’s stock, valued at $2,730,915. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Christine Houston sold 10,104 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now directly owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The disclosure for this sale can be found here. Insiders have sold 21,896 shares of company stock worth $1,617,903 in the last quarter. Insiders own 0.68% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in ESRX. SeaCrest Wealth Management LLC acquired a new stake in shares of Express Scripts during the fourth quarter worth approximately $105,000. Bank of Nova Scotia Trust Co. acquired a new stake in shares of Express Scripts during the third quarter worth approximately $120,000. Aevitas Wealth Management Inc. acquired a new stake in shares of Express Scripts during the fourth quarter worth approximately $128,000. Financial Gravity Companies Inc. acquired a new stake in shares of Express Scripts during the fourth quarter worth approximately $142,000. Finally, Monroe Bank & Trust MI grew its position in shares of Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after buying an additional 970 shares in the last quarter. 89.08% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Markets Daily and is owned by of Markets Daily. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.themarketsdaily.com/2018/03/12/express-scripts-esrx-earns-equal-weight-rating-from-analysts-at-barclays.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply